Human endothelial cells inhibit platelet aggregation by separately stimulating platelet cyclic AMP and cyclic GMP
- 1 May 1989
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 164 (1) , 103-110
- https://doi.org/10.1016/0014-2999(89)90236-7
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Endothelium-derived hyperpolarizing a new endogenous inhibitor from the vascular endotheliumTrends in Pharmacological Sciences, 1988
- Activation of guanylate cyclase and inhibition of platelet aggregation by endothelium-derived relaxing factor released from cultured cellsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1988
- Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factorNature, 1987
- Stimulation of soluble guanylate cyclase by endothelium-derived relaxing factor from cultured endothelial cellsEuropean Journal of Pharmacology, 1987
- Cyclic guanosine monophosphate as a mediator of vasodilation.Journal of Clinical Investigation, 1986
- Effects of atrial natriuretic factor, sodium nitroprusside, and acetylcholine on cyclic GMP levels and relaxation in rat aortaEuropean Journal of Pharmacology, 1985
- The Pharmacological and Physiological Role of Cyclic GMP in Vascular Smooth Muscle RelaxationAnnual Review of Pharmacology and Toxicology, 1985
- The Role of Endothelium in the Responses of Vascular Smooth Muscle to DrugsAnnual Review of Pharmacology and Toxicology, 1984
- Formation and elimination of prostacyclin metabolites in the cat in vivo as determined by radioimmunoassay of unextracted plasmaEuropean Journal of Pharmacology, 1981
- A simple direct assay for cyclic amp in plasma and other biological samples using an improved competitive protein binding techniqueClinica Chimica Acta; International Journal of Clinical Chemistry, 1974